Société Générale — Major Shareholding Notification 2026

Apr 22, 2026

National Storage Mechanism | Additional information

RNS Number : 5298B

Societe Generale SA

22 April 2026

Ap27

FORM 8.3

IRISH TAKEOVER PANEL

OPENING POSITION DISCLOSURE/DEALING DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER

RULES, 2022 BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

1.             KEY INFORMATION

(a)   Full name of discloser	SOCIETE GENERALE SA
(b)   Owner or controller of interests and short positions disclosed, if different from 1(a) The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.	BAWAG Group AG
(c)   Name of offeror/offeree in relation to whose relevant securities this form relates Use a separate form for each offeror/offeree
(d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree (Note 1)
(e)   Date position held/dealing undertaken For an opening position disclosure, state the latest practicable date prior to the disclosure	21/04/2026
(f)    In addition to the company in 1(c) above, is the discloser also making disclosures in respect of any other party to the offer? If it is a cash offer or possible cash offer, state "N/A"	Yes: Permanent TSB Group Holdings plc

2.             INTERESTS AND SHORT POSITIONS

If there are interests and short positions to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2 for each additional class of relevant security.

Ap28

Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

(Note 2)

Class of relevant security (Note 3)	€0.01 ordinary shares
	Interests		Short positions
Number	%	Number	%
(1)   Relevant securities owned and/or controlled	137,175	0.18	56,453	0.07
(2)   Cash-settled derivatives	382,847	0.50	341,353	0.44
(3)   Stock-settled derivatives (including options) and agreements to purchase/ sell	0	0.00	0	0.00
Total	*787,895	1.02	397,806	0.52

*Include the holding of 267,873 shares on borrow products.

Details of options including rights to subscribe for new securities and any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8.

3.             DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE (Note 4)

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

(a)           Purchases and sales

Class of relevant security	Purchase/sale	Number of securities	Price per unit EUR (Note 5)
€0.01 ordinary shares	Purchase	549	155.1161
€0.01 ordinary shares	Purchase	50	153.8
€0.01 ordinary shares	Purchase	56	151
€0.01 ordinary shares	Purchase	60	151.6
€0.01 ordinary shares	Purchase	61	152.1
€0.01 ordinary shares	Purchase	64	151.2
€0.01 ordinary shares	Purchase	67	153.9
€0.01 ordinary shares	Purchase	90	153.8
€0.01 ordinary shares	Purchase	25	154.2
€0.01 ordinary shares	Purchase	20	148.2
€0.01 ordinary shares	Purchase	150	147.8
€0.01 ordinary shares	Purchase	100	155
€0.01 ordinary shares	Purchase	65	146
€0.01 ordinary shares	Purchase	71	146
€0.01 ordinary shares	Purchase	4	153.9
€0.01 ordinary shares	Purchase	14	153.9
€0.01 ordinary shares	Purchase	19	153.9
€0.01 ordinary shares	Purchase	19	153.9
€0.01 ordinary shares	Purchase	23	154.2
€0.01 ordinary shares	Purchase	29	153.9
€0.01 ordinary shares	Purchase	32	150.8
€0.01 ordinary shares	Purchase	33	153.7
€0.01 ordinary shares	Purchase	33	153.9
€0.01 ordinary shares	Purchase	33	154
€0.01 ordinary shares	Purchase	33	154.5
€0.01 ordinary shares	Purchase	33	154.5
€0.01 ordinary shares	Purchase	35	152.7
€0.01 ordinary shares	Purchase	41	153.2
€0.01 ordinary shares	Purchase	41	154.4
€0.01 ordinary shares	Purchase	41	154.7
€0.01 ordinary shares	Purchase	49	154.5
€0.01 ordinary shares	Purchase	52	155.1
€0.01 ordinary shares	Purchase	54	154.8
€0.01 ordinary shares	Purchase	56	154.9
€0.01 ordinary shares	Purchase	58	155.1
€0.01 ordinary shares	Purchase	59	151.3
€0.01 ordinary shares	Purchase	73	155.2
€0.01 ordinary shares	Purchase	20	149.1
€0.01 ordinary shares	Purchase	23	152.4
€0.01 ordinary shares	Purchase	35	152.7
€0.01 ordinary shares	Purchase	36	154.7
€0.01 ordinary shares	Purchase	13	153.7
€0.01 ordinary shares	Purchase	13	153.8
€0.01 ordinary shares	Purchase	14	154.1
€0.01 ordinary shares	Purchase	16	153.9
€0.01 ordinary shares	Purchase	19	153.2
€0.01 ordinary shares	Purchase	20	153.9
€0.01 ordinary shares	Purchase	22	153.9
€0.01 ordinary shares	Purchase	23	153.3
€0.01 ordinary shares	Purchase	25	154.5
€0.01 ordinary shares	Purchase	26	149.1
€0.01 ordinary shares	Purchase	31	154.5
€0.01 ordinary shares	Purchase	38	154.8
€0.01 ordinary shares	Purchase	48	154.5
€0.01 ordinary shares	Purchase	55	154.9
€0.01 ordinary shares	Purchase	56	154.9
€0.01 ordinary shares	Purchase	60	155.1
€0.01 ordinary shares	Purchase	9	154.4
€0.01 ordinary shares	Purchase	20	152.6
€0.01 ordinary shares	Purchase	33	154.1
€0.01 ordinary shares	Purchase	34	154.4
€0.01 ordinary shares	Purchase	37	154
€0.01 ordinary shares	Purchase	41	153.2
€0.01 ordinary shares	Purchase	20	154.4
€0.01 ordinary shares	Purchase	9	155.1
€0.01 ordinary shares	Purchase	69	155.3
€0.01 ordinary shares	Purchase	89	155.4
€0.01 ordinary shares	Purchase	335	154.7
€0.01 ordinary shares	Purchase	22	152.9
€0.01 ordinary shares	Purchase	65	155.2
€0.01 ordinary shares	Purchase	14	151
€0.01 ordinary shares	Sale	8,247	154.6835
€0.01 ordinary shares	Sale	78	154.6691
€0.01 ordinary shares	Sale	490	154.6768
€0.01 ordinary shares	Sale	1,733	154.6691
€0.01 ordinary shares	Sale	92	154.7
€0.01 ordinary shares	Sale	92	154.7
€0.01 ordinary shares	Sale	92	154.7
€0.01 ordinary shares	Sale	549	155.1161
€0.01 ordinary shares	Sale	2	154.5
€0.01 ordinary shares	Sale	3	154.5
€0.01 ordinary shares	Sale	21	154.6
€0.01 ordinary shares	Sale	42	154.6
€0.01 ordinary shares	Sale	73	154.6
€0.01 ordinary shares	Sale	87	154.6
€0.01 ordinary shares	Sale	113	154.9
€0.01 ordinary shares	Sale	398	154.7
€0.01 ordinary shares	Sale	100	149.4
€0.01 ordinary shares	Sale	2	154.4
€0.01 ordinary shares	Sale	3	154.5
€0.01 ordinary shares	Sale	10	154.5
€0.01 ordinary shares	Sale	15	154.4
€0.01 ordinary shares	Sale	15	154.5
€0.01 ordinary shares	Sale	16	154.4
€0.01 ordinary shares	Sale	16	154.6
€0.01 ordinary shares	Sale	29	154.6
€0.01 ordinary shares	Sale	31	154.6
€0.01 ordinary shares	Sale	33	154.4
€0.01 ordinary shares	Sale	33	154.4
€0.01 ordinary shares	Sale	33	154.5
€0.01 ordinary shares	Sale	33	154.6
€0.01 ordinary shares	Sale	33	154.6
€0.01 ordinary shares	Sale	39	154.9
€0.01 ordinary shares	Sale	40	154.6
€0.01 ordinary shares	Sale	51	154.9
€0.01 ordinary shares	Sale	59	154.6
€0.01 ordinary shares	Sale	75	154.6
€0.01 ordinary shares	Sale	239	154.9
€0.01 ordinary shares	Sale	230	155.2
€0.01 ordinary shares	Sale	59	152
€0.01 ordinary shares	Sale	7	155
€0.01 ordinary shares	Sale	100	148.2
€0.01 ordinary shares	Sale	260	151.4
€0.01 ordinary shares	Sale	98	154.7
€0.01 ordinary shares	Sale	71	153.8
€0.01 ordinary shares	Sale	187	154.7
€0.01 ordinary shares	Sale	71	153.8
€0.01 ordinary shares	Sale	19	147.7
€0.01 ordinary shares	Sale	33	152
€0.01 ordinary shares	Sale	33	152.1
€0.01 ordinary shares	Sale	34	148.4
€0.01 ordinary shares	Sale	34	149.3
€0.01 ordinary shares	Sale	43	148.8
€0.01 ordinary shares	Sale	45	149.2
€0.01 ordinary shares	Sale	76	150.9
€0.01 ordinary shares	Sale	10	148.4
€0.01 ordinary shares	Sale	14	148
€0.01 ordinary shares	Sale	14	148
€0.01 ordinary shares	Sale	14	148.1
€0.01 ordinary shares	Sale	14	148.4
€0.01 ordinary shares	Sale	14	149.7
€0.01 ordinary shares	Sale	14	150.8
€0.01 ordinary shares	Sale	15	148.6
€0.01 ordinary shares	Sale	25	148.4
€0.01 ordinary shares	Sale	26	151.9
€0.01 ordinary shares	Sale	32	149.3
€0.01 ordinary shares	Sale	41	148.8
€0.01 ordinary shares	Sale	92	154.7
€0.01 ordinary shares	Sale	28	150
€0.01 ordinary shares	Sale	320	154.7

Ap29

(b)           Cash-settled derivative transactions

Class of relevant security	Product description e.g. CFD	Nature of dealing e.g. opening/ closing a long/ short position, increasing/ reducing a long/ short position	Number of reference securities (Note 6)	Price per unit EUR (Note 5)
€0.01 ordinary shares	CFD	Increasing a long position	1,733	154.66905943
€0.01 ordinary shares	CFD	Increasing a long position	490	154.67679592
€0.01 ordinary shares	CFD	Reducing a short position	78	154.66910256
€0.01 ordinary shares	CFD	Reducing a short position	8,247	154.68350915
€0.01 ordinary shares	Listed Call Warrant	Increasing a long position	1.4	77.9
€0.01 ordinary shares	Listed Call Warrant	Increasing a long position	29	35.6
€0.01 ordinary shares	Listed Call Warrant	Increasing a long position	26.6	23.9
€0.01 ordinary shares	Listed Call Warrant	Increasing a long position	18.4	27.6
€0.01 ordinary shares	Listed Call Warrant	Increasing a long position	8,100	2.7
€0.01 ordinary shares	Listed Call Warrant	Increasing a long position	720	6.4
€0.01 ordinary shares	Listed Call Warrant	Increasing a long position	720	6.4
€0.01 ordinary shares	Listed Call Warrant	Reducing a long position	1.4	75.4
€0.01 ordinary shares	Listed Call Warrant	Reducing a long position	1	75.7
€0.01 ordinary shares	Listed Call Warrant	Reducing a long position	5	46
€0.01 ordinary shares	Listed Call Warrant	Reducing a long position	29	34.3
€0.01 ordinary shares	Listed Call Warrant	Reducing a long position	52.5	19.1
€0.01 ordinary shares	Listed Call Warrant	Reducing a long position	620	6.4
€0.01 ordinary shares	Listed Call Warrant	Reducing a long position	720	6.4
€0.01 ordinary shares	Listed Call Warrant	Reducing a long position	720	6.4
€0.01 ordinary shares	Listed Put Warrant	Increasing a short position	100	18.7

(c)           Stock-settled derivative transactions (including options)

(i)            Writing, selling, purchasing or varying

Class of relevant security	Product description e.g. call option	Writing, purchasing, selling, varying etc.	Number of securities to which option relates (Note 6)	Exercise price per unit	Type e.g. American, European etc.	Expiry date	Option money paid/ received per unit

(ii)           Exercise

Class of relevant security	Product description e.g. call option	Exercising/ exercised against	Number of securities	Exercise price per unit (Note 5)

(d)           Other dealings (including transactions in respect of new securities) (Note 3)

Class of relevant security	Nature of dealing e.g. subscription, conversion, exercise	Details	Price per unit (if applicable) (Note 5)

Ap30

4.             OTHER INFORMATION

(a)           Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer. Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

(b)           Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

(c)           Attachments

Is a Supplemental Form 8 attached?	NO

Date of disclosure	22/04/2026
Contact name	Société Générale - Disclosure team
Telephone number	+33 1 42 14 92 74

Public disclosures under Rule 8.3 of the Rules must be made to a Regulatory Information Service.

Ap31

NOTES ON FORM 8.3

1.             See the definition of "connected fund manager" in Rule 2.2 of Part A of the Rules.

2.             See the definition of "interest in a relevant security" in Rule 2.5 of Part A of the Rules and see Rule 8.6(a) and (b) of Part B of the Rules.

3.             See the definition of "relevant securities" in Rule 2.1 of Part A of the Rules.

4.             See the definition of "dealing" in Rule 2.1 of Part A of the Rules.

5.             If the economic exposure to changes in the price of securities is limited, for example, by virtue of a stop loss arrangement relating to a spread bet, full details must be given.

6.             See Rule 2.5(d) of Part A of the Rules.

7.             If details included in a disclosure under Rule 8 are incorrect, they should be corrected as soon as practicable in a subsequent disclosure. Such disclosure should state clearly that it corrects details disclosed previously, identify the disclosure or disclosures being corrected, and provide sufficient detail for the reader to understand the nature of the corrections. In the case of any doubt, the Panel should be consulted.

For full details of disclosure requirements, see Rule 8 of the Rules. If in doubt, consult the Panel.

References in these notes to "the Rules" are to the Irish Takeover Panel Act, 1997, Takeover Rules, 2022.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

ITPFLFEFSLIFFIR